| |
 |
|
Class Information
Number: 424/188.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Amino acid sequence disclosed in whole or in part; or conjugate, complex, or fusion protein or fusion polypeptide including the same > Disclosed amino acid sequence derived from virus > Retroviridae (e.g., feline leukemia, etc.) > Immunodeficiency virus (e.g., hiv, etc.)
Description: Subject matter wherein the virus is one that is associated with an immunodeficiency syndrome such as AIDS in humans or an AIDS-related syndrome in animals.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6716429 |
Stabilization of envelope glycoprotein trimers by disulfide bonds introduced into a gp 41 glycoprotein ectodomain |
Apr. 6, 2004 |
| 6713064 |
Immune enhancing agent for treating HIV infected humans |
Mar. 30, 2004 |
| 6709828 |
PROCESS FOR THE DETERMINATION OF PEPTIDES CORRESPONDING TO IMMUNOLOGICALLY IMPORTANT EPITOPES AND THEIR USE IN A PROCESS FOR DETERMINATION OF ANTIBODIES OR BIOTINYLATED PEPTIDES CORRESPONDING |
Mar. 23, 2004 |
| 6710173 |
Stabilized viral envelope proteins and uses thereof |
Mar. 23, 2004 |
| 6706268 |
Human deficiency virus type-1 (HIV-1) peptide encoded by the VIF gene |
Mar. 16, 2004 |
| 6696289 |
Replication-competent recombinant Sabin type 1 strain of poliovirus |
Feb. 24, 2004 |
| 6667151 |
Vaccines and immunotherapeutics derived from the human immunodeficiency virus (HIV) trans-activator of transcription protein for the treatment and prevention of HIV disease |
Dec. 23, 2003 |
| 6667295 |
DNA vaccine against feline immunodeficiency virus |
Dec. 23, 2003 |
| 6664041 |
Method for preparing a viral extract containing HIV-II RNA |
Dec. 16, 2003 |
| 6656471 |
HIV-specific T-cell induction |
Dec. 2, 2003 |
| 6653081 |
Methods for monitoring antiretroviral therapy and guiding therapeutic decision in the treatment of HIV/AIDS |
Nov. 25, 2003 |
| 6635472 |
Retrovirus and viral vectors |
Oct. 21, 2003 |
| 6627395 |
Methods for the propagation, isolation, identification, and preparation of human immunodeficiency virus type 1 (HIV-1) |
Sep. 30, 2003 |
| 6620416 |
Method for treating HIV |
Sep. 16, 2003 |
| 6610294 |
Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds |
Aug. 26, 2003 |
| 6602505 |
Viral chimeras comprised of CAEV and HIV-1 genetic elements |
Aug. 5, 2003 |
| 6602705 |
Expression of HIV polypeptides and production of virus-like particles |
Aug. 5, 2003 |
| 6596279 |
Immunodeficiency recombinant poxvirus |
Jul. 22, 2003 |
| 6585979 |
HIV envelope polypeptides and immunogenic composition |
Jul. 1, 2003 |
| 6573078 |
Compounds which inhibit HIV replication |
Jun. 3, 2003 |
| 6555112 |
Peptides derived from the lymphadenopathy-associated virus (LAV) envelope coding region |
Apr. 29, 2003 |
| 6544780 |
Adenovirus vector with multiple expression cassettes |
Apr. 8, 2003 |
| 6544527 |
Non-infectious, immunogenic, human immunodeficiency virus-like particles devoid of long terminal repeats and a functional pol coding region |
Apr. 8, 2003 |
| 6541458 |
Feline calicivirus genes and vaccines in particular recombinant vaccines |
Apr. 1, 2003 |
| 6541003 |
Conditionally controlled, attenuated HIV vaccine |
Apr. 1, 2003 |
| 6538127 |
Synthetic HIV-2 envelope genes containing modifications that lead to optimized expression in bacteria |
Mar. 25, 2003 |
| 6531313 |
Invasive bacterial vectors for expressing alphavirus replicons |
Mar. 11, 2003 |
| 6525173 |
Process for expression and production of recombinant protein hybrid protein (p24/p17) derived from human immunodeficiency viruses (HIV-1) |
Feb. 25, 2003 |
| 6524588 |
Attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
Feb. 25, 2003 |
| 6514692 |
Method for treatment of immunodeficiency virus infection |
Feb. 4, 2003 |
| 6514691 |
Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2 |
Feb. 4, 2003 |
| 6509018 |
Non-M non-O HIV strains, fragments and uses |
Jan. 21, 2003 |
| 6503753 |
Method for the development of an HIV vaccine |
Jan. 7, 2003 |
| 6492104 |
EIA test using nondenatured HIV antigen for early detection of HIV infection |
Dec. 10, 2002 |
| 6489306 |
Method of intranasal gene transfer for protection against respiratory infection |
Dec. 3, 2002 |
| 6482412 |
Polypeptide having human HIV inhibitory activity, a gene encoding the polypeptide, a method to produce the polypeptide |
Nov. 19, 2002 |
| 6468539 |
Protein targeting into HIV virions based on HIV-1 VPR fusion molecules |
Oct. 22, 2002 |
| 6455265 |
Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection |
Sep. 24, 2002 |
| 6451322 |
Retrovirus like particles made non infectious by a plurality of mutations |
Sep. 17, 2002 |
| 6447778 |
Peptide compositions for the treatment of HIV infection |
Sep. 10, 2002 |
| 6447993 |
Multi-subtype FIV vaccines |
Sep. 10, 2002 |
| 6440657 |
Nucleic acids and peptides of human immunodeficiency virus type (HIV-1) |
Aug. 27, 2002 |
| 6432675 |
Combinatorial polypeptide antigens |
Aug. 13, 2002 |
| 6428952 |
Methods and kits employing LAV antigens for the detection of HIV-1-specific antibodies |
Aug. 6, 2002 |
| 6429009 |
Composition and method of imparting resistivity to HIV superinfection to cells |
Aug. 6, 2002 |
| 6428790 |
Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use |
Aug. 6, 2002 |
| 6426412 |
Nucleic acids encoding human immunodeficiency virus type 1 genetic suppressor elements |
Jul. 30, 2002 |
| 6426073 |
Variant of LAV viruses |
Jul. 30, 2002 |
| 6403092 |
Immune response modulator alpha-2 macroglobulin complex |
Jun. 11, 2002 |
| 6399067 |
Methods and compositions for impairing multiplication of HIV-1 |
Jun. 4, 2002 |
|
|
|
